glutathione peroxidase inhibitors JKE-1674 The glutathione peroxidase family: Discoveries
Description
The Leerink analysts expect CagriSema to demonstrate best-ever weight loss any day now, adding that we expect at least high-20% weight loss. Still, CagriSema could pose practical challenges for Novo, particularly in terms of commercialization
10.1038/S41397-022-00288-2 123 ZhouZ.XuM.-J.GaoB
Despite promising preclinical data, the translational potential of polyphenols to human clinical settings remains constrained by their poor bioavailability, limited bloodbrain barrier (BBB) penetration, and rapid metabolic degradation (Figueira, Menezes, et al
A.EcheverraC.KalergisA
